MedAvail Holdings (STU:73M) Other Stockholders Equity: €32.75 Mil (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:73M MedAvail Holdings Inc STU:73M
12 GF Score
Price €11.05
View Full Analysis

What is MedAvail Holdings Other Stockholders Equity?

MedAvail Holdings STU:73M 12 Other Stockholders Equity is €32.75 Mil as of Jun. 2023. GuruFocus rates STU:73M with a GF Score™ of 12/100.

MedAvail Holdings's Other Stockholders Equity for the quarter that ended in Jun. 2023 was €32.75 Mil.

MedAvail Holdings's quarterly Other Stockholders Equity declined from Dec. 2022 (€10.52 Mil) to Mar. 2023 (€10.47 Mil) but then increased from Mar. 2023 (€10.47 Mil) to Jun. 2023 (€32.75 Mil).

MedAvail Holdings's annual Other Stockholders Equity declined from Dec. 2020 (€2.15 Mil) to Dec. 2021 (€1.22 Mil) but then increased from Dec. 2021 (€1.22 Mil) to Dec. 2022 (€10.52 Mil).

MedAvail Holdings Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for MedAvail Holdings's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedAvail Holdings Other Stockholders Equity Chart

MedAvail Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Other Stockholders Equity
0.63 2.15 1.22 10.52

MedAvail Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.40 11.26 10.52 10.47 32.75
STU:73M
12GF Score
MedAvail Holdings Inc STU:73M
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MedAvail Holdings Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €32.75 Mil mean?
MedAvail Holdings (STU:73M) has a Other Stockholders Equity of €32.75 Mil as of Jun. 2023. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on MedAvail Holdings and its competitors.
Is MedAvail Holdings' Other Stockholders Equity too high?
MedAvail Holdings' current Other Stockholders Equity is €32.75 Mil. Overall, MedAvail Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does MedAvail Holdings' Other Stockholders Equity compare to HEWA and BIMI?
MedAvail Holdings' Other Stockholders Equity of €32.75 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Healthcare Providers & Services company?
A good Other Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on MedAvail Holdings and its competitors. MedAvail Holdings's current Other Stockholders Equity is €32.75 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedAvail Holdings stock overvalued right now?
MedAvail Holdings (STU:73M) has a current Other Stockholders Equity of €32.75 Mil. The current Other Stockholders Equity is €32.75 Mil. MedAvail Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For MedAvail Holdings (STU:73M), the current Other Stockholders Equity is €32.75 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedAvail Holdings Business Description

Address 4720 East Cotton Gin Loop, Suite 220, Phoenix, AZ, USA, 85040
MedAvail Holdings Inc is a telehealth-enabled pharmacy technology company. It operates in two segments: Retail Pharmacy Services and Pharmacy Technology. It generates the majority of revenue from the Retail Pharmacy Services segment, which is into operating SpotRx, a full-service retail pharmacy utilizing MedAvail's automated pharmacy technology, servicing Medicare patients in the United States. The Pharmacy Technology segment develops and commercializes the MedCenter for direct sale or lease to third-party customers.
12GF Score

Get the complete analysis for STU:73M

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.05
Price